(Q36536423)

English

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study

scientific article published on 8 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

cystic fibrosis

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

Stefanie Hennig

1

object named as

Stefanie Hennig

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Ross Norris

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Carl M J Kirkpatrick

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

8 November 2007

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

65

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

502-510

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Early airway infection, inflammation, and lung function in cystic fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Evaluation of four once-daily aminoglycoside dosing nomograms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Population pharmacokinetics of gentamicin in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

A suggested approach to once‐daily aminoglycoside dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Prediction of creatinine clearance from serum creatinine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Renal clearance and tissue accumulation of gentamicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

30 September 2017

Tobramycin population pharmacokinetics in neonates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

28 June 2018

Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

28 June 2018

A size standard for pharmacokinetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

28 June 2018

Once-daily dosing of gentamicin: experience with therapeutic drug monitoring and Bayesian pharmacokinetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

28 June 2018

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

28 June 2018

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291370

28 June 2018

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03045.X

21 January 2018

Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03045.X

21 January 2018

Quantification of lean bodyweight.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03045.X

21 January 2018

Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03045.X

21 January 2018

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17995972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Target concentration intervention: beyond Y2K

1 reference

https://pubmed.ncbi.nlm.nih.gov/17995972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17995972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17995972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17995972

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2007.03045.X

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36536423&oldid=2148128402"